NPI: 1174791883 · HEMET, CA 92545 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/15/2008
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/15/2008 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 35,913 | $1.38M |
| 2019 | 49,133 | $1.50M |
| 2020 | 37,529 | $1.36M |
| 2021 | 34,751 | $1.20M |
| 2022 | 33,836 | $1.60M |
| 2023 | 42,844 | $2.16M |
| 2024 | 25,741 | $1.90M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 83,565 | 7,224 | $10.82M |
| A4657 | Syringe, with or without needle, each | 7,342 | 3,985 | $252K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 69,772 | 5,220 | $5K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 642 | 182 | $4K |
| 90677 | 27 | 26 | $4K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 41,899 | 3,098 | $3K |
| 0250 | 12,031 | 823 | $3K | |
| J1756 | Injection, iron sucrose, 1 mg | 23,197 | 5,554 | $3K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,517 | 869 | $2K |
| 90747 | 122 | 121 | $923.10 | |
| 90661 | 24 | 24 | $769.62 | |
| 85041 | 3,396 | 3,210 | $237.04 | |
| 82108 | 445 | 420 | $91.52 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,748 | 1,406 | $88.14 |
| 90662 | 123 | 120 | $73.66 | |
| 90674 | 191 | 175 | $28.51 | |
| 83970 | 2,942 | 2,766 | $5.58 | |
| 82728 | 2,052 | 1,924 | $1.93 | |
| 83550 | 1,914 | 1,767 | $1.10 | |
| 83540 | 2,255 | 2,092 | $0.91 | |
| 85048 | 3,371 | 3,186 | $0.36 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 443 | 69 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 402 | 399 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 169 | 168 | $0.00 |
| 82746 | 58 | 58 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 14 | 14 | $0.00 |
| 82607 | 86 | 69 | $0.00 |